Characterization of the Renal and Hormonal Effects of Three Novel Anti-Mineralocorticoids in Vitro and in Vivo

Antimineralocorticoid compounds are widely prescribed for the treatment of essential hypertension and primary or secondary hyper-aldosteronism. Spironolactone is the most commonly used drug of this type. Its administration however is limited by its anti-androgenic action.